original articlessupportive careEfficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
supportive care
Under a Creative Commons license
open access
Keywords
chemotherapy-induced nausea and vomiting
CYP3A4
fosaprepitant
single-dose
substance P
Cited by (0)
Copyright © 2012 THE AUTHORS. Published by Elsevier Ltd.